Avantax Advisory Services Inc. Purchases Shares of 4,178 Everus (NYSE:ECG)

Avantax Advisory Services Inc. acquired a new stake in shares of Everus (NYSE:ECGFree Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 4,178 shares of the company’s stock, valued at approximately $275,000.

Several other large investors have also modified their holdings of the stock. EverSource Wealth Advisors LLC acquired a new position in Everus during the fourth quarter worth approximately $56,000. HighTower Advisors LLC purchased a new stake in Everus during the fourth quarter valued at about $577,000. Moors & Cabot Inc. acquired a new stake in Everus during the fourth quarter worth about $1,124,000. Investors Research Corp acquired a new stake in Everus during the fourth quarter worth about $169,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of Everus in the 4th quarter worth about $921,000.

Insider Transactions at Everus

In other news, Director Edward A. Ryan bought 1,400 shares of the stock in a transaction that occurred on Tuesday, February 25th. The shares were acquired at an average cost of $38.02 per share, for a total transaction of $53,228.00. Following the completion of the acquisition, the director now owns 14,928 shares in the company, valued at approximately $567,562.56. This represents a 10.35 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Rocca Michael Della bought 1,050 shares of Everus stock in a transaction dated Tuesday, February 18th. The shares were acquired at an average price of $47.56 per share, with a total value of $49,938.00. Following the completion of the purchase, the director now directly owns 2,027 shares in the company, valued at $96,404.12. This trade represents a 107.47 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 3,750 shares of company stock worth $153,853.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Stifel Nicolaus decreased their price target on Everus from $85.00 to $67.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Oppenheimer upped their price target on shares of Everus from $70.00 to $80.00 and gave the company an “outperform” rating in a report on Tuesday, January 7th. Finally, Wolfe Research assumed coverage on Everus in a research report on Tuesday, December 3rd. They set a “peer perform” rating on the stock.

Check Out Our Latest Analysis on Everus

Everus Trading Down 6.6 %

Shares of ECG stock opened at $38.62 on Wednesday. The stock has a 50 day moving average price of $53.27. Everus has a 12 month low of $36.96 and a 12 month high of $77.93. The company has a quick ratio of 1.50, a current ratio of 1.58 and a debt-to-equity ratio of 0.47.

Everus (NYSE:ECGGet Free Report) last released its quarterly earnings results on Tuesday, February 11th. The company reported $0.67 EPS for the quarter, missing the consensus estimate of $0.73 by ($0.06). On average, equities analysts anticipate that Everus will post 2.49 earnings per share for the current fiscal year.

Everus Profile

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Featured Articles

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.